Logo image of HZO

MARINEMAX INC (HZO) Stock Fundamental Analysis

USA - NYSE:HZO - US5679081084 - Common Stock

27.13 USD
+1.98 (+7.87%)
Last: 10/14/2025, 8:04:00 PM
27.13 USD
0 (0%)
After Hours: 10/14/2025, 8:04:00 PM
Fundamental Rating

3

HZO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. While HZO is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, HZO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HZO was profitable.
In the past year HZO had a positive cash flow from operations.
HZO had positive earnings in each of the past 5 years.
In multiple years HZO reported negative operating cash flow during the last 5 years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a Return On Assets value of -1.08%, HZO perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
HZO's Return On Equity of -2.85% is in line compared to the rest of the industry. HZO outperforms 47.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.78%, HZO is in line with its industry, outperforming 50.83% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HZO is below the industry average of 12.17%.
The last Return On Invested Capital (3.78%) for HZO is well below the 3 year average (9.69%), which needs to be investigated, but indicates that HZO had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROIC 3.78%
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

In the last couple of years the Profit Margin of HZO has declined.
Looking at the Operating Margin, with a value of 5.00%, HZO is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
HZO's Operating Margin has improved in the last couple of years.
The Gross Margin of HZO (32.41%) is worse than 61.67% of its industry peers.
In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 5%
PM (TTM) N/A
GM 32.41%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

HZO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HZO has been increased compared to 1 year ago.
Compared to 5 years ago, HZO has more shares outstanding
HZO has a worse debt/assets ratio than last year.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.83 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
HZO's Altman-Z score of 1.83 is in line compared to the rest of the industry. HZO outperforms 42.50% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that HZO has dependencies on debt financing.
The Debt to Equity ratio of HZO (1.17) is worse than 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACC0.41
WACC9.23%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

HZO has a Current Ratio of 1.21. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HZO (1.21) is worse than 60.83% of its industry peers.
A Quick Ratio of 0.29 indicates that HZO may have some problems paying its short term obligations.
With a Quick ratio value of 0.29, HZO is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for HZO have decreased strongly by -56.03% in the last year.
HZO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.01% yearly.
Looking at the last year, HZO shows a decrease in Revenue. The Revenue has decreased by -5.78% in the last year.
The Revenue has been growing by 14.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%

3.2 Future

The Earnings Per Share is expected to grow by 9.17% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.34% on average over the next years.
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.01 indicates a rather expensive valuation of HZO.
Based on the Price/Earnings ratio, HZO is valued a bit cheaper than 67.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. HZO is around the same levels.
With a Price/Forward Earnings ratio of 14.48, HZO is valued correctly.
Based on the Price/Forward Earnings ratio, HZO is valued a bit cheaper than 66.67% of the companies in the same industry.
HZO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.01
Fwd PE 14.48
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HZO is valued cheaper than 88.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.08
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.79
EPS Next 2Y-6%
EPS Next 3Y9.17%

0

5. Dividend

5.1 Amount

HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARINEMAX INC

NYSE:HZO (10/14/2025, 8:04:00 PM)

After market: 27.13 0 (0%)

27.13

+1.98 (+7.87%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners94.73%
Inst Owner Change-0.02%
Ins Owners2.55%
Ins Owner Change7.49%
Market Cap582.21M
Analysts81.67
Price Target34.85 (28.46%)
Short Float %16.98%
Short Ratio8.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.16%
Min EPS beat(2)-59.12%
Max EPS beat(2)83.44%
EPS beat(4)2
Avg EPS beat(4)48.21%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)3
Avg EPS beat(8)6.98%
EPS beat(12)5
Avg EPS beat(12)4.55%
EPS beat(16)9
Avg EPS beat(16)9.43%
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)8.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.32%
PT rev (1m)1.49%
PT rev (3m)0.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-140.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE 24.01
Fwd PE 14.48
P/S 0.25
P/FCF N/A
P/OCF 55.07
P/B 0.62
P/tB 1.55
EV/EBITDA 5.08
EPS(TTM)1.13
EY4.17%
EPS(NY)1.87
Fwd EY6.9%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)0.49
OCFY1.82%
SpS108.12
BVpS43.83
TBVpS17.55
PEG (NY)N/A
PEG (5Y)4.79
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROCE 7.75%
ROIC 3.78%
ROICexc 4.06%
ROICexgc 5.57%
OM 5%
PM (TTM) N/A
GM 32.41%
FCFM N/A
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
ROICexc(3y)11.72%
ROICexc(5y)15.7%
ROICexgc(3y)16.73%
ROICexgc(5y)22.44%
ROCE(3y)16.44%
ROCE(5y)19.71%
ROICexcg growth 3Y-46.03%
ROICexcg growth 5Y-2.42%
ROICexc growth 3Y-44.7%
ROICexc growth 5Y-7.52%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 6.72
Cap/Depr 134.26%
Cap/Sales 2.77%
Interest Coverage 1.5
Cash Conversion 6.45%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.29
Altman-Z 1.83
F-Score4
WACC9.23%
ROIC/WACC0.41
Cap/Depr(3y)198.93%
Cap/Depr(5y)172.82%
Cap/Sales(3y)2.58%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A
EBIT growth 1Y-14.52%
EBIT growth 3Y-15.1%
EBIT growth 5Y16.21%
EBIT Next Year-13.84%
EBIT Next 3Y9.34%
EBIT Next 5YN/A
FCF growth 1Y82.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.35%
OCF growth 3YN/A
OCF growth 5YN/A